Loading insider details...
Beta
Latest Form 4 (Jun 3, 2026): Grant/Award of 96,000 ONCY shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 3, 2026 | ONCOLYTICS BIOTECH INC (ONCY) | Grant/Award | 96,000 | n/a |
| Mar 3, 2026 | PDS Biotechnology Corp (PDSB) | Grant/Award | 54,876 | n/a |
| Jul 15, 2025 | ZyVersa Therapeutics, Inc. (ZVSA) | Grant/Award | 136,900 | n/a |
| Jun 11, 2025 | PDS Biotechnology Corp (PDSB) | Grant/Award | 22,700 | n/a |
| Mar 3, 2025 | PDS Biotechnology Corp (PDSB) | Purchase | 15,061 | $25.0K |
| Jul 19, 2024 | ZyVersa Therapeutics, Inc. (ZVSA) | Grant/Award | 1,627 | n/a |
| Jun 25, 2024 | PDS Biotechnology Corp (PDSB) | Grant/Award | 9,000 | n/a |
| Mar 7, 2024 | Ambrx Biopharma, Inc. (AMAM) | Disposition to Issuer | 12,142 | n/a |
| Jul 17, 2023 | PDS Biotechnology Corp (PDSB) | Grant/Award | 9,000 | n/a |
| Dec 15, 2022 | ZyVersa Therapeutics, Inc. (ZVSA) | Grant/Award | 448,909 | n/a |